436 related articles for article (PubMed ID: 26660324)
1. Prognostic and predictive miRNA biomarkers in bladder, kidney and prostate cancer: Where do we stand in biomarker development?
Schubert M; Junker K; Heinzelmann J
J Cancer Res Clin Oncol; 2016 Aug; 142(8):1673-95. PubMed ID: 26660324
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA in prostate, bladder, and kidney cancer: a systematic review.
Catto JW; Alcaraz A; Bjartell AS; De Vere White R; Evans CP; Fussel S; Hamdy FC; Kallioniemi O; Mengual L; Schlomm T; Visakorpi T
Eur Urol; 2011 May; 59(5):671-81. PubMed ID: 21296484
[TBL] [Abstract][Full Text] [Related]
3. Urine microRNAs as potential noninvasive biomarkers in urologic cancers.
Mlcochova H; Hezova R; Stanik M; Slaby O
Urol Oncol; 2014 Jan; 32(1):41.e1-9. PubMed ID: 24035473
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA in prostate, bladder, and kidney cancer.
Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs as regulators of signal transduction in urological tumors.
Fendler A; Stephan C; Yousef GM; Jung K
Clin Chem; 2011 Jul; 57(7):954-68. PubMed ID: 21632885
[TBL] [Abstract][Full Text] [Related]
6. Recent scenario of microRNA as diagnostic and prognostic biomarkers of prostate cancer.
Shukla KK; Misra S; Pareek P; Mishra V; Singhal B; Sharma P
Urol Oncol; 2017 Mar; 35(3):92-101. PubMed ID: 27890424
[TBL] [Abstract][Full Text] [Related]
7. Urinary MicroRNAs as Biomarkers of Urological Cancers: A Systematic Review.
Aveta A; Cilio S; Contieri R; Spena G; Napolitano L; Manfredi C; Franco A; Crocerossa F; Cerrato C; Ferro M; Del Giudice F; Verze P; Lasorsa F; Salonia A; Nair R; Walz J; Lucarelli G; Pandolfo SD
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446024
[TBL] [Abstract][Full Text] [Related]
8. The Potential of MicroRNAs as Prostate Cancer Biomarkers.
Fabris L; Ceder Y; Chinnaiyan AM; Jenster GW; Sorensen KD; Tomlins S; Visakorpi T; Calin GA
Eur Urol; 2016 Aug; 70(2):312-22. PubMed ID: 26806656
[TBL] [Abstract][Full Text] [Related]
9. Mirna Expression in Bladder Cancer and Their Potential Role in Clinical Practice.
Blanca A; Cheng L; Montironi R; Moch H; Massari F; Fiorentino M; Raspollini MR; Scarpelli M; Lopez-Beltran A
Curr Drug Metab; 2017 Oct; 18(8):712-722. PubMed ID: 28524002
[TBL] [Abstract][Full Text] [Related]
10. A panel of eight-miRNA signature as a potential biomarker for predicting survival in bladder cancer.
Zhou H; Tang K; Xiao H; Zeng J; Guan W; Guo X; Xu H; Ye Z
J Exp Clin Cancer Res; 2015 May; 34(1):53. PubMed ID: 25991007
[TBL] [Abstract][Full Text] [Related]
11. Carcinoma-associated antigens MK-1 and CEA in urological cancers.
Tomita Y; Arakawa F; Hirose Y; Liao S; Khare PD; Kuroki M; Yamamoto T; Ariyoshi A; Kuroki M
Anticancer Res; 2000; 20(2A):793-7. PubMed ID: 10810356
[TBL] [Abstract][Full Text] [Related]
12. microRNA expression profiles as decision-making biomarkers in the management of bladder cancer.
Amir S; Mabjeesh NJ
Histol Histopathol; 2017 Feb; 32(2):107-119. PubMed ID: 27586262
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs and cancer: current state and future perspectives in urologic oncology.
Schaefer A; Jung M; Kristiansen G; Lein M; Schrader M; Miller K; Stephan C; Jung K
Urol Oncol; 2010; 28(1):4-13. PubMed ID: 19117772
[TBL] [Abstract][Full Text] [Related]
14. miRNAs as biomarkers in prostate cancer.
Casanova-Salas I; Rubio-Briones J; Fernández-Serra A; López-Guerrero JA
Clin Transl Oncol; 2012 Nov; 14(11):803-11. PubMed ID: 22855165
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers of aggressiveness in genitourinary tumors with emphasis on kidney, bladder, and prostate cancer.
Cimadamore A; Gasparrini S; Santoni M; Cheng L; Lopez-Beltran A; Battelli N; Massari F; Giunchi F; Fiorentino M; Scarpelli M; Montironi R
Expert Rev Mol Diagn; 2018 Jul; 18(7):645-655. PubMed ID: 29912582
[TBL] [Abstract][Full Text] [Related]
16. Emerging Utility of Urinary Cell-free Nucleic Acid Biomarkers for Prostate, Bladder, and Renal Cancers.
Lin SY; Linehan JA; Wilson TG; Hoon DSB
Eur Urol Focus; 2017 Apr; 3(2-3):265-272. PubMed ID: 28753876
[TBL] [Abstract][Full Text] [Related]
17. The microRNA signatures: aberrantly expressed miRNAs in prostate cancer.
Sharma N; Baruah MM
Clin Transl Oncol; 2019 Feb; 21(2):126-144. PubMed ID: 29951892
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic review.
Endzeliņš E; Melne V; Kalniņa Z; Lietuvietis V; Riekstiņa U; Llorente A; Linē A
Mol Cancer; 2016 May; 15(1):41. PubMed ID: 27189160
[TBL] [Abstract][Full Text] [Related]
19. microRNA biomarkers in body fluids of prostate cancer patients.
Kuner R; Brase JC; Sültmann H; Wuttig D
Methods; 2013 Jan; 59(1):132-7. PubMed ID: 22652624
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs in prostate cancer: Functional role as biomarkers.
Kanwal R; Plaga AR; Liu X; Shukla GC; Gupta S
Cancer Lett; 2017 Oct; 407():9-20. PubMed ID: 28823964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]